| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10742384 | Journal of Geriatric Oncology | 2015 | 8 Pages |
Abstract
SABR is less costly than surgery. While lobectomy may be cost-effective compared to SABR, sublobar resection is less likely to be cost-effective. Assessment of the relative value of SABR versus surgical therapy requires further research.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Benjamin D. Smith, Jing Jiang, Joe Y. Chang, James Welsh, Anna Likhacheva, Thomas A. Buchholz, Stephen G. Swisher, Shervin M. Shirvani,